PIRS - Pieris Pharmaceuticals Inc (PIRS) CEO Stephen S. Yoder on Q1 2022 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc (PIRS) Q1 2022 Earnings Conference Call May 11, 2022, 8:00 AM ET Company Participants Stephen S. Yoder – Chief Executive Officer, President, Director Thomas Bures – Senior Vice President, Chief Financial Officer Tim Demuth – Chief Medical Officer Conference Call Participants Jessica Hanitta Hui – Evercore ISI Roger Jiale Song – Jefferies Matthew Phipps – William Blair & Company Presentation Operator Good day and welcome to your Pieris Pharmaceuticals, Inc. First Quarter Earnings Call. All lines have been placed on a listen-only mode and the floor will be open for your questions and comments following the presentation. [Operator Instructions]. At this time, it is my pleasure to turn the floor over to Thomas Bures, CFO. Sir, the floor is yours. Thomas Bures Thank you and good morning, everyone. And thank you for joining us for our first quarter 2022 conference call and corporate update. On the call
For further details see:
Pieris Pharmaceuticals, Inc (PIRS) CEO Stephen S. Yoder on Q1 2022 Results - Earnings Call Transcript